Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |